Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy

Sowmya Parameswaran, Shashank Manohar Dravid, Pooja Teotia, Raghu R. Krishnamoorthy, Fang Qiu, Carol B Toris, John Morrison, Iqbal Ahmad

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Glaucoma, where the retinal ganglion cells (RGCs) carrying the visual signals from the retina to the visual centers in the brain are progressively lost, is the most common cause of irreversible blindness. The management approaches, whether surgical, pharmacological, or neuroprotective do not reverse the degenerative changes. The stem cell approach to replace dead RGCs is a viable option but currently faces several barriers, such as the lack of a renewable, safe, and ethical source of RGCs that are functional and could establish contacts with bona fide targets. To address these barriers, we have derived RGCs from the easily accessible adult limbal cells, reprogrammed to pluripotency by a non-nucleic acid approach, thus circumventing the risk of insertional mutagenesis. The generation of RGCs from the induced pluripotent stem (iPS) cells, also accomplished non-cell autonomously, recapitulated the developmental mechanism, ensuring the predictability and stability of the acquired phenotype, comparable to that of native RGCs at biochemical, molecular, and functional levels. More importantly, the induced RGCs expressed axonal guidance molecules and demonstrated the potential to establish contacts with specific targets. Furthermore, when transplanted in the rat model of ocular hypertension, these cells incorporated into the host RGC layer and expressed RGC-specific markers. Transplantation of these cells in immune-deficient mice did not produce tumors. Together, our results posit retinal progenitors generated from non-nucleic acid-derived iPS cells as a safe and robust source of RGCs for replacing dead RGCs in glaucoma.

Original languageEnglish (US)
Pages (from-to)1743-1758
Number of pages16
JournalSTEM CELLS
Volume33
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Retinal Ganglion Cells
Induced Pluripotent Stem Cells
Glaucoma
Ocular Hypertension
Acids
Insertional Mutagenesis
Cell Transplantation
Blindness
Retina
Stem Cells
Pharmacology
Phenotype

Keywords

  • Glaucoma
  • Induced pluripotent stem cells
  • Non-cell autonomous
  • Retinal ganglion cells
  • Teratoma

ASJC Scopus subject areas

  • Molecular Medicine
  • Developmental Biology
  • Cell Biology

Cite this

Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy. / Parameswaran, Sowmya; Dravid, Shashank Manohar; Teotia, Pooja; Krishnamoorthy, Raghu R.; Qiu, Fang; Toris, Carol B; Morrison, John; Ahmad, Iqbal.

In: STEM CELLS, Vol. 33, No. 6, 01.06.2015, p. 1743-1758.

Research output: Contribution to journalArticle

Parameswaran, S, Dravid, SM, Teotia, P, Krishnamoorthy, RR, Qiu, F, Toris, CB, Morrison, J & Ahmad, I 2015, 'Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy', STEM CELLS, vol. 33, no. 6, pp. 1743-1758. https://doi.org/10.1002/stem.1987
Parameswaran, Sowmya ; Dravid, Shashank Manohar ; Teotia, Pooja ; Krishnamoorthy, Raghu R. ; Qiu, Fang ; Toris, Carol B ; Morrison, John ; Ahmad, Iqbal. / Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy. In: STEM CELLS. 2015 ; Vol. 33, No. 6. pp. 1743-1758.
@article{8af25984f2d248a1ba1a11e5c5f86007,
title = "Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy",
abstract = "Glaucoma, where the retinal ganglion cells (RGCs) carrying the visual signals from the retina to the visual centers in the brain are progressively lost, is the most common cause of irreversible blindness. The management approaches, whether surgical, pharmacological, or neuroprotective do not reverse the degenerative changes. The stem cell approach to replace dead RGCs is a viable option but currently faces several barriers, such as the lack of a renewable, safe, and ethical source of RGCs that are functional and could establish contacts with bona fide targets. To address these barriers, we have derived RGCs from the easily accessible adult limbal cells, reprogrammed to pluripotency by a non-nucleic acid approach, thus circumventing the risk of insertional mutagenesis. The generation of RGCs from the induced pluripotent stem (iPS) cells, also accomplished non-cell autonomously, recapitulated the developmental mechanism, ensuring the predictability and stability of the acquired phenotype, comparable to that of native RGCs at biochemical, molecular, and functional levels. More importantly, the induced RGCs expressed axonal guidance molecules and demonstrated the potential to establish contacts with specific targets. Furthermore, when transplanted in the rat model of ocular hypertension, these cells incorporated into the host RGC layer and expressed RGC-specific markers. Transplantation of these cells in immune-deficient mice did not produce tumors. Together, our results posit retinal progenitors generated from non-nucleic acid-derived iPS cells as a safe and robust source of RGCs for replacing dead RGCs in glaucoma.",
keywords = "Glaucoma, Induced pluripotent stem cells, Non-cell autonomous, Retinal ganglion cells, Teratoma",
author = "Sowmya Parameswaran and Dravid, {Shashank Manohar} and Pooja Teotia and Krishnamoorthy, {Raghu R.} and Fang Qiu and Toris, {Carol B} and John Morrison and Iqbal Ahmad",
year = "2015",
month = "6",
day = "1",
doi = "10.1002/stem.1987",
language = "English (US)",
volume = "33",
pages = "1743--1758",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "6",

}

TY - JOUR

T1 - Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy

AU - Parameswaran, Sowmya

AU - Dravid, Shashank Manohar

AU - Teotia, Pooja

AU - Krishnamoorthy, Raghu R.

AU - Qiu, Fang

AU - Toris, Carol B

AU - Morrison, John

AU - Ahmad, Iqbal

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Glaucoma, where the retinal ganglion cells (RGCs) carrying the visual signals from the retina to the visual centers in the brain are progressively lost, is the most common cause of irreversible blindness. The management approaches, whether surgical, pharmacological, or neuroprotective do not reverse the degenerative changes. The stem cell approach to replace dead RGCs is a viable option but currently faces several barriers, such as the lack of a renewable, safe, and ethical source of RGCs that are functional and could establish contacts with bona fide targets. To address these barriers, we have derived RGCs from the easily accessible adult limbal cells, reprogrammed to pluripotency by a non-nucleic acid approach, thus circumventing the risk of insertional mutagenesis. The generation of RGCs from the induced pluripotent stem (iPS) cells, also accomplished non-cell autonomously, recapitulated the developmental mechanism, ensuring the predictability and stability of the acquired phenotype, comparable to that of native RGCs at biochemical, molecular, and functional levels. More importantly, the induced RGCs expressed axonal guidance molecules and demonstrated the potential to establish contacts with specific targets. Furthermore, when transplanted in the rat model of ocular hypertension, these cells incorporated into the host RGC layer and expressed RGC-specific markers. Transplantation of these cells in immune-deficient mice did not produce tumors. Together, our results posit retinal progenitors generated from non-nucleic acid-derived iPS cells as a safe and robust source of RGCs for replacing dead RGCs in glaucoma.

AB - Glaucoma, where the retinal ganglion cells (RGCs) carrying the visual signals from the retina to the visual centers in the brain are progressively lost, is the most common cause of irreversible blindness. The management approaches, whether surgical, pharmacological, or neuroprotective do not reverse the degenerative changes. The stem cell approach to replace dead RGCs is a viable option but currently faces several barriers, such as the lack of a renewable, safe, and ethical source of RGCs that are functional and could establish contacts with bona fide targets. To address these barriers, we have derived RGCs from the easily accessible adult limbal cells, reprogrammed to pluripotency by a non-nucleic acid approach, thus circumventing the risk of insertional mutagenesis. The generation of RGCs from the induced pluripotent stem (iPS) cells, also accomplished non-cell autonomously, recapitulated the developmental mechanism, ensuring the predictability and stability of the acquired phenotype, comparable to that of native RGCs at biochemical, molecular, and functional levels. More importantly, the induced RGCs expressed axonal guidance molecules and demonstrated the potential to establish contacts with specific targets. Furthermore, when transplanted in the rat model of ocular hypertension, these cells incorporated into the host RGC layer and expressed RGC-specific markers. Transplantation of these cells in immune-deficient mice did not produce tumors. Together, our results posit retinal progenitors generated from non-nucleic acid-derived iPS cells as a safe and robust source of RGCs for replacing dead RGCs in glaucoma.

KW - Glaucoma

KW - Induced pluripotent stem cells

KW - Non-cell autonomous

KW - Retinal ganglion cells

KW - Teratoma

UR - http://www.scopus.com/inward/record.url?scp=84929791632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929791632&partnerID=8YFLogxK

U2 - 10.1002/stem.1987

DO - 10.1002/stem.1987

M3 - Article

VL - 33

SP - 1743

EP - 1758

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 6

ER -